1. Home
  2. Companies
  3. Epistemix

About

Epistemix is a computational modeling company headquartered in Pittsburgh. It builds agent-based simulation software and generates synthetic population data, enabling organisations to model human behaviour and test interventions in uncertain scenarios.

The company's technology is applied across several sectors, including public health, life sciences, insurance, healthcare, government, and enterprise strategy. Its core technical domains span agent-based simulation, synthetic population data generation, data science, and advanced simulations.

Epistemix provides two principal products: agent-based simulation software for modelling complex human systems, and high-resolution synthetic population data that serves as realistic modelling infrastructure.

Similar companies

Worldscape logoWO

Worldscape

Worldscape develops an AI-native platform that unifies data across environments for predictive modeling and decision-making using geospatial and simulation technologies.

Repli5 logoRE

Repli5

Repli5 provides generative AI-powered synthetic data solutions to create realistic training data for computer vision applications across industries like automotive and robotics.

Electric Twin logoET

Electric Twin

Electric Twin builds a synthetic audience platform combining large language models, machine learning and social science research to predict how real users will respond.

UniversalAGI logoUN

UniversalAGI

UniversalAGI develops foundation AI models for physics simulation and autonomous agents to automate physical systems engineering, aiming to drastically reduce simulation times for industries like aerospace and automotive.

VL

Vsurvey Labs

Vurvey Labs is a Cincinnati-based applied AI company building generative and agentic AI products, including People Models, from millions of real consumer interviews for enterprise clients.

Pathos logoPA

Pathos

Pathos is a clinical-stage biotech using AI, biological modeling, and large-scale oncology data to develop a platform for simulating and optimizing precision oncology clinical trials.